{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:40:52Z","timestamp":1768527652328,"version":"3.49.0"},"posted":{"date-parts":[[2025,8,27]]},"group-title":"Neuroscience","reference-count":86,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"crossref","award":["071739"],"award-info":[{"award-number":["071739"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIDA","award":["040484"],"award-info":[{"award-number":["040484"]}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Vulnerable Brain Project"},{"name":"Charles H. Revson Senior Fellowship in Biomedical Science"},{"name":"Andrew Ellis and Emily Segal Investigator Grant from the Brain and Behavior Research Foundation"},{"name":"Fonds de Recherche du Qu\u00e9bec \u2013 Sant\u00e9"},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"crossref","award":["126157"],"award-info":[{"award-number":["126157"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007321","name":"Finding A Cure for Epilepsy and Seizures","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007321","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ruth L. Kirschstein National Research Service Award","award":["100293"],"award-info":[{"award-number":["100293"]}]},{"name":"NIH","award":["GM007308"],"award-info":[{"award-number":["GM007308"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,8,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Cannabidiol (CBD) decreases seizures in patients with severe pediatric-onset epilepsies including Dravet, Lennox-Gastaut, and Tuberous Sclerosis syndromes. However, the effects of CBD on neuronal activity and circuits remain obscure. In the mouse hippocampus, we found that CBD causes a GPR55-independent decrease in CA1 pyramidal neuron firing frequency and a GPR55-dependent reduction in CA3 to CA1 hippocampal activity propagation. CBD-mediated decrease in high-frequency activity was mimicked by GPR55 antagonism and prevented by GPR55 deletion and blockade of GABAergic transmission. Dampening high-frequency activity was accompanied by increased recruitment of parvalbumin+ (PV)-INs and reduced recruitment of somatostatin+ (SST)-INs, leveraging the inhibitory subcircuit to limit propagation of hyperactivity. CBD-induced attenuation of high frequency spike propagation was mimicked by pharmacological enhancement and optogenetic engagement of PV-INs. Such increased on-demand recruitment of PV-INs dampened propagation of high-frequency activity to hippocampal CA1 similarly to CBD. We predict that CBD potentially curbs propagation and perpetuation of seizure activity via these mechanisms.<\/jats:p>","DOI":"10.1101\/2025.08.26.672420","type":"posted-content","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:25:13Z","timestamp":1756283113000},"source":"Crossref","is-referenced-by-count":0,"title":["Cannabidiol dampens propagation of hippocampal hyperactivity and differentially modulates feedforward and feedback inhibition"],"prefix":"10.64898","author":[{"given":"Simon","family":"Chamberland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan C.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica R.","family":"Nebet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orrin","family":"Devinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Tsien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025083001150875000_2025.08.26.672420v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03010"},{"key":"2025083001150875000_2025.08.26.672420v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46478-3"},{"key":"2025083001150875000_2025.08.26.672420v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2017.11.012"},{"key":"2025083001150875000_2025.08.26.672420v1.4","doi-asserted-by":"publisher","DOI":"10.1113\/JP275317"},{"key":"2025083001150875000_2025.08.26.672420v1.5","doi-asserted-by":"publisher","DOI":"10.1002\/cne.24226"},{"key":"2025083001150875000_2025.08.26.672420v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(02)00586-X"},{"key":"2025083001150875000_2025.08.26.672420v1.7","doi-asserted-by":"publisher","DOI":"10.1002\/hipo.22488"},{"key":"2025083001150875000_2025.08.26.672420v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2012.02.004"},{"key":"2025083001150875000_2025.08.26.672420v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/35077553"},{"key":"2025083001150875000_2025.08.26.672420v1.10","doi-asserted-by":"crossref","unstructured":"Chamberland S , Nebet ER , Valero M , Hanani M , Egger R , Larsen SB , Eyring KW , Buzsaki G , Tsien RW (2023) Brief synaptic inhibition persistently interrupts firing of fast-spiking interneurons. Neuron.","DOI":"10.1101\/2022.08.02.502477"},{"key":"2025083001150875000_2025.08.26.672420v1.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2306382121"},{"key":"2025083001150875000_2025.08.26.672420v1.12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1211591109"},{"key":"2025083001150875000_2025.08.26.672420v1.13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fncel.2018.00151","article-title":"Specificity, Versatility, and Continual Development: The Power of Optogenetics for Epilepsy Research","volume":"12","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"2025083001150875000_2025.08.26.672420v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/82900"},{"key":"2025083001150875000_2025.08.26.672420v1.15","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00049.2021"},{"key":"2025083001150875000_2025.08.26.672420v1.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611618"},{"key":"2025083001150875000_2025.08.26.672420v1.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714631"},{"key":"2025083001150875000_2025.08.26.672420v1.18","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-21-07873.2003"},{"key":"2025083001150875000_2025.08.26.672420v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/nn1952"},{"key":"2025083001150875000_2025.08.26.672420v1.20","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.13626"},{"key":"2025083001150875000_2025.08.26.672420v1.21","doi-asserted-by":"publisher","DOI":"10.1177\/2042098611411127"},{"key":"2025083001150875000_2025.08.26.672420v1.22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/10738584211017009","article-title":"Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications","volume":"28","year":"2022","journal-title":"Neuroscientist"},{"key":"2025083001150875000_2025.08.26.672420v1.23","doi-asserted-by":"crossref","first-page":"1211230","DOI":"10.3389\/fphys.2023.1211230","article-title":"Editorial: Cannabinoid interactions with ion channels, receptors, and the bio-membrane","volume":"14","year":"2023","journal-title":"Front Physiol"},{"key":"2025083001150875000_2025.08.26.672420v1.24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.004929"},{"key":"2025083001150875000_2025.08.26.672420v1.25","doi-asserted-by":"publisher","DOI":"10.1038\/nn1688"},{"key":"2025083001150875000_2025.08.26.672420v1.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2006387"},{"key":"2025083001150875000_2025.08.26.672420v1.27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030159"},{"key":"2025083001150875000_2025.08.26.672420v1.28","first-page":"1255263","article-title":"Interneurons","volume":"345","year":"2014","journal-title":"Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function. Science"},{"key":"2025083001150875000_2025.08.26.672420v1.29","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0377-3"},{"key":"2025083001150875000_2025.08.26.672420v1.30","doi-asserted-by":"crossref","unstructured":"Izhikevich EM (2007) Dynamical Systems in Neuroscience: The Geometry of Excitability and Bursting. Cambridge, MA: MIT Press.","DOI":"10.7551\/mitpress\/2526.001.0001"},{"key":"2025083001150875000_2025.08.26.672420v1.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2022.114141"},{"key":"2025083001150875000_2025.08.26.672420v1.32","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.159145"},{"key":"2025083001150875000_2025.08.26.672420v1.33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1212\/WNL.0000000000005756","article-title":"Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"91","year":"2018","journal-title":"Neurology"},{"key":"2025083001150875000_2025.08.26.672420v1.34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1711351114"},{"key":"2025083001150875000_2025.08.26.672420v1.35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.050187"},{"key":"2025083001150875000_2025.08.26.672420v1.36","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.113.204180"},{"key":"2025083001150875000_2025.08.26.672420v1.37","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt348"},{"key":"2025083001150875000_2025.08.26.672420v1.38","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14202"},{"key":"2025083001150875000_2025.08.26.672420v1.39","doi-asserted-by":"publisher","DOI":"10.1126\/science.1149381"},{"key":"2025083001150875000_2025.08.26.672420v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2376"},{"key":"2025083001150875000_2025.08.26.672420v1.41","doi-asserted-by":"crossref","first-page":"106937","DOI":"10.1016\/j.eplepsyres.2022.106937","article-title":"Modulation of epileptiform activity by three subgroups of GABAergic interneurons in mouse somatosensory cortex","volume":"183","year":"2022","journal-title":"Epilepsy Res"},{"key":"2025083001150875000_2025.08.26.672420v1.42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711278105"},{"key":"2025083001150875000_2025.08.26.672420v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3235"},{"key":"2025083001150875000_2025.08.26.672420v1.44","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00111.2023"},{"key":"2025083001150875000_2025.08.26.672420v1.45","doi-asserted-by":"crossref","unstructured":"Liebergall SR , Goldberg EM (2024) Ndnf Interneuron Excitability Is Spared in a Mouse Model of Dravet Syndrome. J Neurosci 44.","DOI":"10.1523\/JNEUROSCI.1977-23.2024"},{"key":"2025083001150875000_2025.08.26.672420v1.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(96)10070-9"},{"key":"2025083001150875000_2025.08.26.672420v1.47","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s12264-014-1478-4","article-title":"Dysfunction of hippocampal interneurons in epilepsy","volume":"30","year":"2014","journal-title":"Neurosci Bull"},{"key":"2025083001150875000_2025.08.26.672420v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2467"},{"key":"2025083001150875000_2025.08.26.672420v1.49","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3078"},{"key":"2025083001150875000_2025.08.26.672420v1.50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pharmtox-051921-083709","article-title":"A Delightful Trip Along the Pathway of Cannabinoid and Endocannabinoid Chemistry and Pharmacology","volume":"63","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2025083001150875000_2025.08.26.672420v1.51","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80101-4"},{"key":"2025083001150875000_2025.08.26.672420v1.52","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5270-06.2007"},{"key":"2025083001150875000_2025.08.26.672420v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.08.078"},{"key":"2025083001150875000_2025.08.26.672420v1.54","doi-asserted-by":"publisher","DOI":"10.1038\/nature12330"},{"key":"2025083001150875000_2025.08.26.672420v1.55","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww129"},{"key":"2025083001150875000_2025.08.26.672420v1.56","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/epi.14629","article-title":"Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models","volume":"60","year":"2019","journal-title":"Epilepsia"},{"key":"2025083001150875000_2025.08.26.672420v1.57","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3950"},{"key":"2025083001150875000_2025.08.26.672420v1.58","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00007.2017"},{"issue":"Suppl 2","key":"2025083001150875000_2025.08.26.672420v1.59","first-page":"30","article-title":"Epilepsy following cortical injury: cellular and molecular mechanisms as targets for potential prophylaxis","volume":"50","year":"2009","journal-title":"Epilepsia"},{"key":"2025083001150875000_2025.08.26.672420v1.60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1804764115"},{"issue":"Suppl 2","key":"2025083001150875000_2025.08.26.672420v1.61","first-page":"33","article-title":"The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs","volume":"54","year":"2013","journal-title":"Epilepsia"},{"key":"2025083001150875000_2025.08.26.672420v1.62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.yebeh.2016.11.006","article-title":"Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection","volume":"70","year":"2017","journal-title":"Epilepsy & behavior: E&B"},{"key":"2025083001150875000_2025.08.26.672420v1.63","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s13311-015-0375-5","article-title":"Cannabinoids and Epilepsy","volume":"12","year":"2015","journal-title":"Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics"},{"key":"2025083001150875000_2025.08.26.672420v1.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2023.01.018"},{"key":"2025083001150875000_2025.08.26.672420v1.65","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3077"},{"key":"2025083001150875000_2025.08.26.672420v1.66","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv142"},{"key":"2025083001150875000_2025.08.26.672420v1.67","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707460"},{"key":"2025083001150875000_2025.08.26.672420v1.68","doi-asserted-by":"crossref","unstructured":"Sait LG , Sula A , Ghovanloo MR , Hollingworth D , Ruben PC , Wallace BA (2020) Cannabidiol interactions with voltage-gated sodium channels. Elife 9.","DOI":"10.7554\/eLife.58593"},{"key":"2025083001150875000_2025.08.26.672420v1.69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-024-00546-6","article-title":"Developmental and epileptic encephalopathies","volume":"10","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"2025083001150875000_2025.08.26.672420v1.70","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5117-14.2015"},{"key":"2025083001150875000_2025.08.26.672420v1.71","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2244-16.2017"},{"key":"2025083001150875000_2025.08.26.672420v1.72","doi-asserted-by":"crossref","unstructured":"Shore AN , Li K , Safari M , Qunies AM , Spitznagel BD , Weaver CD , Emmitte K , Frankel W , Weston MC (2024) Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on somatostatin\u2013 and parvalbumin-expressing cortical GABAergic neurons. Elife 13.","DOI":"10.7554\/eLife.92915.4"},{"key":"2025083001150875000_2025.08.26.672420v1.73","doi-asserted-by":"publisher","DOI":"10.1002\/hipo.450010106"},{"key":"2025083001150875000_2025.08.26.672420v1.74","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jamaneurol.2022.2635","article-title":"Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy","volume":"79","year":"2022","journal-title":"JAMA Neurol"},{"key":"2025083001150875000_2025.08.26.672420v1.75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1211204110"},{"key":"2025083001150875000_2025.08.26.672420v1.76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1411131111"},{"key":"2025083001150875000_2025.08.26.672420v1.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.07.026"},{"key":"2025083001150875000_2025.08.26.672420v1.78","doi-asserted-by":"crossref","first-page":"100017","DOI":"10.1016\/j.molpha.2025.100017","article-title":"Ion channels and G protein-coupled receptors: Cannabidiol actions on disorders of excitability and synaptic excitatory-inhibitory ratio","volume":"107","year":"2025","journal-title":"Mol Pharmacol"},{"key":"2025083001150875000_2025.08.26.672420v1.79","doi-asserted-by":"crossref","first-page":"e70176","DOI":"10.1111\/ejn.70176","article-title":"Differential Modulation of Dopamine D2 Receptor on Somatostatin and Parvalbumin Interneurons in the CA1 Area of the Dorsal Hippocampus","volume":"62","year":"2025","journal-title":"Eur J Neurosci"},{"key":"2025083001150875000_2025.08.26.672420v1.80","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.brs.2016.06.055","article-title":"Optogenetic Approaches for Controlling Seizure Activity","volume":"9","year":"2016","journal-title":"Brain Stimul"},{"key":"2025083001150875000_2025.08.26.672420v1.81","doi-asserted-by":"crossref","unstructured":"Vaasjo LO , Kotermanski S , Patel T , Shi HJ , Machold R , Chamberland S (2025) Dendritic inhibition terminates plateau potentials in CA1 pyramidal neurons. bioRxiv.","DOI":"10.1101\/2025.06.05.657434"},{"key":"2025083001150875000_2025.08.26.672420v1.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2019.11.014"},{"key":"2025083001150875000_2025.08.26.672420v1.83","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100000561"},{"key":"2025083001150875000_2025.08.26.672420v1.84","unstructured":"World Health Organization (2019) Epilepsy: a public health imperative. In."},{"key":"2025083001150875000_2025.08.26.672420v1.85","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3216-20.2021"},{"key":"2025083001150875000_2025.08.26.672420v1.86","doi-asserted-by":"crossref","unstructured":"Zhang HB , Heckman L , Niday Z , Jo S , Fujita A , Shim J , Pandey R , Al Jandal H , Jayakar S , Barrett LB , Smith J , Woolf CJ , Bean BP (2022) Cannabidiol activates neuronal Kv7 channels. Elife 11.","DOI":"10.7554\/eLife.73246"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.08.26.672420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:25:29Z","timestamp":1768469129000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.08.26.672420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":86,"URL":"https:\/\/doi.org\/10.1101\/2025.08.26.672420","relation":{},"subject":[],"published":{"date-parts":[[2025,8,27]]},"subtype":"preprint"}}